Jane Street’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-213,826
Closed -$1.9M 6190
2025
Q1
$1.9M Buy
213,826
+195,658
+1,077% +$1.74M ﹤0.01% 2312
2024
Q4
$249K Sell
18,168
-103,013
-85% -$1.41M ﹤0.01% 4845
2024
Q3
$3.32M Buy
121,181
+19,684
+19% +$539K ﹤0.01% 1772
2024
Q2
$2.48M Buy
101,497
+66,711
+192% +$1.63M ﹤0.01% 2488
2024
Q1
$742K Sell
34,786
-28,020
-45% -$597K ﹤0.01% 3588
2023
Q4
$1.2M Buy
62,806
+21,248
+51% +$407K ﹤0.01% 3092
2023
Q3
$667K Sell
41,558
-62,333
-60% -$1,000K ﹤0.01% 3312
2023
Q2
$2.41M Buy
103,891
+36,372
+54% +$843K ﹤0.01% 2229
2023
Q1
$1.57M Buy
67,519
+37,745
+127% +$877K ﹤0.01% 2313
2022
Q4
$432K Buy
29,774
+9,207
+45% +$134K ﹤0.01% 3563
2022
Q3
$392K Buy
+20,567
New +$392K ﹤0.01% 3896
2022
Q2
Sell
-33,814
Closed -$852K 6011
2022
Q1
$852K Buy
33,814
+12,712
+60% +$320K ﹤0.01% 3141
2021
Q4
$583K Buy
+21,102
New +$583K ﹤0.01% 3298
2021
Q3
Sell
-21,200
Closed -$648K 5647
2021
Q2
$648K Buy
21,200
+8,234
+64% +$252K ﹤0.01% 3137
2021
Q1
$395K Sell
12,966
-37,818
-74% -$1.15M ﹤0.01% 3619
2020
Q4
$1.01M Sell
50,784
-2,570
-5% -$50.9K ﹤0.01% 2111
2020
Q3
$696K Buy
53,354
+11,759
+28% +$153K ﹤0.01% 2131
2020
Q2
$471K Buy
+41,595
New +$471K ﹤0.01% 2589
2020
Q1
Sell
-21,429
Closed -$584K 3771
2019
Q4
$584K Buy
21,429
+9,619
+81% +$262K ﹤0.01% 2099
2019
Q3
$338K Buy
+11,810
New +$338K ﹤0.01% 2590
2019
Q2
Hold
0
3818
2018
Q2
Sell
-10,364
Closed -$306K 3550
2018
Q1
$306K Buy
+10,364
New +$306K ﹤0.01% 2501
2017
Q3
Sell
-14,458
Closed -$374K 3213
2017
Q2
$374K Buy
+14,458
New +$374K ﹤0.01% 2133
2016
Q4
Sell
-14,029
Closed -$289K 2884
2016
Q3
$289K Buy
+14,029
New +$289K ﹤0.01% 2255
2016
Q1
Sell
-23,461
Closed -$1.01M 2873
2015
Q4
$1.01M Buy
23,461
+10,691
+84% +$462K 0.01% 1044
2015
Q3
$479K Buy
+12,770
New +$479K ﹤0.01% 1601
2014
Q2
Sell
-13,318
Closed -$455K 2626
2014
Q1
$455K Buy
13,318
+485
+4% +$16.6K 0.01% 1419
2013
Q4
$269K Buy
+12,833
New +$269K ﹤0.01% 1502